Glial Therapeutics, LLC
Boston, MA
- UEI
- ZJUSQDWF7BK8
- CAGE
- 9V5H2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- Hale Building, 60 Fenwood Rd, Boston, MA 02115, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Targeting AVB8 integrin to restore astrocyte-microglia crosstalk to treat alzheimer's disease - phase i application… | National Institute on Aging | $487,092 |
Quick answers
What is Glial Therapeutics, LLC's UEI?
Glial Therapeutics, LLC's Unique Entity ID (UEI) in SAM.gov is ZJUSQDWF7BK8.
What is Glial Therapeutics, LLC's CAGE code?
Glial Therapeutics, LLC's CAGE code is 9V5H2.
What is Glial Therapeutics, LLC's primary NAICS code?
Glial Therapeutics, LLC's primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).
Where is Glial Therapeutics, LLC located?
Glial Therapeutics, LLC's physical address in SAM.gov is Hale Building, 60 Fenwood Rd, Boston, MA 02115, USA.
Is Glial Therapeutics, LLC registered in SAM.gov?
Yes. Glial Therapeutics, LLC's SAM.gov registration is active through March 25, 2027.
What is Glial Therapeutics, LLC's most recent federal award?
Glial Therapeutics, LLC's most recent federal grant award is Targeting AVB8 integrin to restore astrocyte-microglia crosstalk to treat alzheimer's disease - phase i application… (R41AG092194), from National Institute on Aging, on September 20, 2025.
On GovTribe
See Glial Therapeutics, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors